Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F12%3A10124512" target="_blank" >RIV/00216208:11160/12:10124512 - isvavai.cz</a>
Result on the web
<a href="http://onlinelibrary.wiley.com/doi/10.1111/j.1469-0691.2012.03973.x/full" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1111/j.1469-0691.2012.03973.x/full</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/j.1469-0691.2012.03973.x" target="_blank" >10.1111/j.1469-0691.2012.03973.x</a>
Alternative languages
Result language
angličtina
Original language name
Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009
Original language description
The study aimed to identify targets for quality improvement in antifungal use in European hospitals and determine the variability of such prescribing. Hospitals that participated in the European Surveillance of Antimicrobial Consumption Point PrevalenceSurveys (ESAC-PPS) were included. The WHO Anatomical Therapeutic Chemical (ATC) classification for antimycotics for systemic use (J02) 2009 version was used. Demographic data and information about indications and diagnoses were collected in 2008 and 2009. From 99 053 patients, 29 324 (29.6%) received antimicrobials. Antifungals represented 1529 of 40 878 (3.7%) antimicrobials. Antifungals were mainly (54.2%) administered orally. Hospital-acquired infections represented 44.5% of indications for antifungals followed by medical prophylaxis at 31.2%. The site of infection was not defined in 36.0% of cases but the most commonly targeted sites were respiratory (19.2%) and gastrointestinal (18.8%). The most used antifungal was fluconazole (60.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Clinical Microbiology and Infection
ISSN
1198-743X
e-ISSN
—
Volume of the periodical
18
Issue of the periodical within the volume
10
Country of publishing house
GB - UNITED KINGDOM
Number of pages
7
Pages from-to
"E389"-"E395"
UT code for WoS article
000308579400003
EID of the result in the Scopus database
—